Cervical cancer screenings

Who are we expecting to the cervical cancer screening? 

In 2024 we invite women (including uninsured) who are born in 1959, 1964, 1969, 1974, 1979, 1984, 1989, 1994.

All people belonging to the target group will receive a screening invitation at the postal and/or e-mail address provided in the population register. Persons belonging to the target group can also find the screening invitation at the patient portal www.digilugu.ee. A woman on the invite list can come to the screening even if she has not received the invitation. 

The further goal of the screening is to prevent people getting cervical cancer and dying from it. The more immediate goal is to find patients with precancerous conditions of the cervix and cervical cancer at the earliest possible stage. 

Where to come? 

Please come to the screening at the gynaecological outpatient clinic in the Mustamäe hospital block of the North Estonia Medical Centre (19 Sütiste, Tallinn), register no. 15. 

We offer two receptions a week: on Tuesday afternoon at 4.30 p.m. to 6.20 p.m. and on Friday morning at 9 a.m. to 10.50 a.m. 

You can register for the screening by calling 617 1049, at the national eBooking system, or by calling the secretary directly at 617 2361 on weekdays at 9 a.m. to 2 p.m. 

After the screening 

We will inform you about the results of the screening according to your wishes either by e-mail, regular mail, or by phone. In case of changes in the analysis result, we offer the opportunity to visit a gynaecologist to receive explanations about the findings and to test for STDs and HPV, if necessary. At the gynaecological outpatient clinic, a colposcopy can be performed along with taking a biopsy, i.e. a sample. If a cervical or other gynaecological malignancy is found, the Medical Centre can perform all the necessary tests to assess the size and spread of the tumour. The treatment of all patients diagnosed with cancer is decided by the gynaecological tumour council in collaboration between the surgeon and the radiotherapy and chemotherapy physicians.